Study on intravesical chemotherapy

Study on intravesical chemotherapy

博士 === 高雄醫學院 === 醫學研究所 === 74 ===

Bibliographic Details
Main Authors:	HUANG, JUN-XIONG, 黃俊雄
Other Authors:	JIANG, JIN-PEI
Format:	Others
Language:	zh-TW
Published:	1986
Online Access:	http://ndltd.ncl.edu.tw/handle/50450673424666847527

Similar Items

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
by: Richmond A. Owusu, et al.
Published: (2013-01-01)

Gel-Based Nanocarrier for Intravesical Chemotherapy Delivery: In Vitro and In Vivo Study
by: Ting-Yu Chen, et al.
Published: (2020-10-01)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
by: Sima P Porten, et al.
Published: (2015-01-01)

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
by: Qiang Ruan, et al.
Published: (2021-02-01)

Intravesical mitomycin C salvage chemotherapy after BCG failure
by: B. D. Lebed, et al.
Published: (2020-02-01)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
by: Zhongbao Zhou, et al.
Published: (2021-05-01)

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01)

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
by: Vincenzo Serretta, et al.
Published: (2015-01-01)

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy
by: Ting-Yu Chen, et al.
Published: (2020-10-01)

The role of Protopine associated with Nuciferine in controlling adverse events during hyperthermic intravesical chemotherapy instillations. A nutraceutical approach to control adverse event during intravesical instillations
by: Francesco Chiancone, et al.
Published: (2020-10-01)

ROLE OF ADJUVANT INTRAVESICAL CHEMOTHERAPY IN THE COMBINED ORGAN-SPARING TREATMENT OF NON-MUSCLE-INVASIVE BLADDER CANCER
by: A. Yu. Zubko, et al.
Published: (2014-07-01)

ROLE OF ADJUVANT INTRAVESICAL CHEMOTHERAPY IN THE COMBINED ORGAN-SPARING TREATMENT OF NON-MUSCLE-INVASIVE BLADDER CANCER
by: A. Yu. Zubko, et al.
Published: (2014-07-01)

Spatial and temporal profile of cisplatin delivery by ultrasound-assisted intravesical chemotherapy in a bladder cancer model.
by: Noboru Sasaki, et al.
Published: (2017-01-01)

A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer
by: Bellat, V., et al.
Published: (2022)

Prospects for the use of the method of intravesical hyperthermic chemotherapy in the treatment of patients with non-muscle invasive bladder cancer
by: Roman Chystiakov
Published: (2021-04-01)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
by: Kang Liu, et al.
Published: (2020-02-01)

COMPARATIVE ANALYSIS OF THE THERAPEUTIC EFFICACY OF PROSPIDINE AND CISPLATIN IN NEOADJUVANT INTRAVESICAL CHEMOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
by: T. I. Shabunina, et al.
Published: (2014-07-01)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2021-01-01)

COMPARATIVE ANALYSIS OF THE THERAPEUTIC EFFICACY OF PROSPIDINE AND CISPLATIN IN NEOADJUVANT INTRAVESICAL CHEMOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
by: T. I. Shabunina, et al.
Published: (2014-07-01)

Comparing adverse effects, short term outcomes, and cost implications of Hyperthermic Intravesical Chemotherapy (HIVEC) with mitomycin-C and intravesical BCG instillation (Moscow-I strain) in the management of intermediate and high-risk NMIBC
by: P. Dev, et al.
Published: (2020-11-01)

Intravesical Migration of an Intrauterine Device
by: Bayram Guner, et al.
Published: (2013-03-01)

Interstitial cystitis - intravesical treatment
by: Fernando Gonçalves de Almeida, et al.
Published: (2019-05-01)

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
by: Zhang Y, et al.
Published: (2016-01-01)

Organ-preserving treatment using neoadjuvant chemotherapy during intravesical immunotherapy with roncoleukin (interleukin-2) for invasive bladder carcinoma
by: S. A. Krasnyi
Published: (2020-03-01)

Development and characterization of intravesical mucoadhesive nanoparticulate formulations of paclitaxel and docetaxel for postoperative chemotherapy in non-muscle-invasive bladder cancer
by: Mugabe, Clement
Published: (2011)

Development and characterization of intravesical mucoadhesive nanoparticulate formulations of paclitaxel and docetaxel for postoperative chemotherapy in non-muscle-invasive bladder cancer
by: Mugabe, Clement
Published: (2011)

Development and characterization of intravesical mucoadhesive nanoparticulate formulations of paclitaxel and docetaxel for postoperative chemotherapy in non-muscle-invasive bladder cancer
by: Mugabe, Clement
Published: (2011)

Intravesical ureterocele masquerading as bladder tumor
by: Suresh Bhat, et al.
Published: (2002-01-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

INTRAVESICAL MIGRATION OF INTRAUTERINE CONTRACEPTIVE DEVICE
by: Abdul Mannan, et al.
Published: (2003-10-01)

Long-term results of adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex in patients with high risk nonmuscle-invasive bladder cancer
by: A. V. Zamyatin, et al.
Published: (2019-04-01)

Adjuvant intravesical chemotherapy with titanium glycerosolvate aquacomplex versus BCG therapy in patients with high risk nonmuscle-invasive bladder cancer
by: A. V. Zamyatin, et al.
Published: (2020-11-01)

Intravesical Chemotherapy after Radical Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma: A Systematic Review and Network Meta-Analysis
by: Sang Hyun Yoo, et al.
Published: (2019-07-01)

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
by: Chunliang Cheng, et al.
Published: (2021-09-01)

Mycobacterial Brain Tuberculomas due to Bacille Calmette-Guérin Intravesical Chemotherapy for Bladder Cancer: A Case Report and Literature Review
by: Vitaly Golub, et al.
Published: (2011-01-01)

The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer
by: Chi-Ping Huang, et al.
Published: (2018)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
by: Di Huang, et al.
Published: (2019-03-01)

Studies on the O plasma and deep UV portable conformable mask
by: HUANG, JUN-XIONG, et al.
Published: (1988)

Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.
by: Shunta Hori, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_c0ptg4misto7bhtlnf8hpicmfe